Zdrowie i gospodarka · 11/03/2014
FDA Releases Draft Guidance on Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Treatment
The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop treatments for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
Source: Federal Register — Food and Drug AdministrationOpen original release →